Brokerage firm Motilal Oswal Wealth Management wrote in a note that India’s Pharma industry is likely to grow between 9% to 11% in financial year 2026, citing a report by CRISIL. The growth will be led by price hikes and new launches in the domestic market and a rise in export demand from regulated markets.
Content retrieved from: https://www.cnbctv18.com/photos/market/top-picks-for-2025-pharma-stocks-mosl-wealth-ipca-piramal-lupin-max-mankind-share-price-19529851.htm.
